CNSX:BIO

Bio-Rad Laboratories Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume265,600 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Bio-Rad Laboratories (CNSX:BIO) Vs. THCX, GLH, ACG, HC, BBM, and LOVE

Should you be buying BIO stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Bio-Rad Laboratories, including (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Blueberries Medical (BBM), and Cannara Biotech (LOVE).

Bio-Rad Laboratories (CNSX:BIO) and (THCX.V) (CVE:THCX) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership.

Analyst Recommendations

This is a summary of current ratings and price targets for Bio-Rad Laboratories and (THCX.V), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bio-Rad Laboratories0000N/A
(THCX.V)0000N/A

Earnings and Valuation

This table compares Bio-Rad Laboratories and (THCX.V)'s revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Rad LaboratoriesN/AN/AN/AN/AN/A
(THCX.V)N/AN/AN/AN/AN/A

Profitability

This table compares Bio-Rad Laboratories and (THCX.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Bio-Rad LaboratoriesN/AN/AN/A
(THCX.V)N/AN/AN/A

Bio-Rad Laboratories (CNSX:BIO) and 31444 (CNSX:GLH) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, dividends, analyst recommendations and profitability.

Analyst Recommendations

This is a breakdown of current ratings for Bio-Rad Laboratories and 31444, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bio-Rad Laboratories0000N/A
314440000N/A

Earnings and Valuation

This table compares Bio-Rad Laboratories and 31444's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Rad LaboratoriesN/AN/AN/AN/AN/A
31444N/AN/AN/AN/AN/A

Profitability

This table compares Bio-Rad Laboratories and 31444's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Bio-Rad LaboratoriesN/AN/AN/A
31444N/AN/AN/A

Bio-Rad Laboratories (CNSX:BIO) and 438280 (CNSX:ACG) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.

Valuation and Earnings

This table compares Bio-Rad Laboratories and 438280's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Rad LaboratoriesN/AN/AN/AN/AN/A
438280N/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations and price targets for Bio-Rad Laboratories and 438280, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bio-Rad Laboratories0000N/A
4382800000N/A

Profitability

This table compares Bio-Rad Laboratories and 438280's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Bio-Rad LaboratoriesN/AN/AN/A
438280N/AN/AN/A

815446 (CNSX:HC) and Bio-Rad Laboratories (CNSX:BIO) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, analyst recommendations and earnings.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for 815446 and Bio-Rad Laboratories, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
8154460000N/A
Bio-Rad Laboratories0000N/A

Profitability

This table compares 815446 and Bio-Rad Laboratories' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
815446N/AN/AN/A
Bio-Rad LaboratoriesN/AN/AN/A

Valuation and Earnings

This table compares 815446 and Bio-Rad Laboratories' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
815446N/AN/AN/AN/AN/A
Bio-Rad LaboratoriesN/AN/AN/AN/AN/A

Bio-Rad Laboratories (CNSX:BIO) and Blueberries Medical (CNSX:BBM) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

Analyst Recommendations

This is a summary of current ratings for Bio-Rad Laboratories and Blueberries Medical, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bio-Rad Laboratories0000N/A
Blueberries Medical0000N/A

Profitability

This table compares Bio-Rad Laboratories and Blueberries Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Bio-Rad LaboratoriesN/AN/AN/A
Blueberries MedicalN/AN/AN/A

Valuation and Earnings

This table compares Bio-Rad Laboratories and Blueberries Medical's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Rad LaboratoriesN/AN/AN/AN/AN/A
Blueberries MedicalN/AN/AN/AN/AN/A

Bio-Rad Laboratories (CNSX:BIO) and Cannara Biotech (CNSX:LOVE) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

Analyst Recommendations

This is a summary of current ratings for Bio-Rad Laboratories and Cannara Biotech, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bio-Rad Laboratories0000N/A
Cannara Biotech0000N/A

Profitability

This table compares Bio-Rad Laboratories and Cannara Biotech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Bio-Rad LaboratoriesN/AN/AN/A
Cannara BiotechN/AN/AN/A

Valuation and Earnings

This table compares Bio-Rad Laboratories and Cannara Biotech's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Rad LaboratoriesN/AN/AN/AN/AN/A
Cannara BiotechN/AN/AN/AN/AN/A


Bio-Rad Laboratories Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
THCX
(THCX.V)
0.6$5.30flatC$0.00N/A0.00High Trading Volume
GLH
31444
0.4N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ACG
438280
0.6N/AN/AC$0.00N/A0.00Gap Down
HC
815446
0.5N/AN/A$0.00N/A0.00Gap Down
BBM
Blueberries Medical
0.6N/AN/A$0.00N/A0.00High Trading Volume
LOVE
Cannara Biotech
0.7N/AN/A$0.00N/A0.00High Trading Volume
CALI
China Auto Logistics
1.3N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
MJ
ETFMG Alternative Harvest ETF
0.5N/AN/A$0.00N/A0.00Gap Down
BOSS
Global X Founder-Run Companies ETF
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
LHS
Liberty Health Sciences
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
LIB
Liberty Leaf
0.5N/AN/AC$0.00N/A0.00High Trading Volume
Gap Down
MMEN
Medmen Enterprises
0.6N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
RQB
Ravenquest Biomed
0.6N/AN/A$0.00N/A0.00High Trading Volume
TGIF
SoFi Weekly Income ETF
0.6N/AN/A$0.00N/A0.00High Trading Volume
Valeant Pharmaceuticals International logo
VRX
Valeant Pharmaceuticals International
0.5N/AN/AC$0.00N/A0.00News Coverage
VRT
Vertiv
0.5N/AN/A$0.00N/A0.00Gap Down
This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.